SSA
COGT icon

Schonfeld Strategic Advisors’s Cogent Biosciences COGT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.33M Buy
+112,463
New +$4.15M 0.03% 534
2025
Q2 		– Sell
-10,080
Closed -$60.4K – 2105
2025
Q1 		$60.4K Buy
10,080
+80
+0.8% +$627 ﹤0.01% 2062
2024
Q4 		$78K Buy
+10,000
New +$99.7K ﹤0.01% 1855
2024
Q1 		– Sell
-260,955
Closed -$1.53M – 2115
2023
Q4 		$1.53M Buy
260,955
+23,425
+10% +$180K 0.01% 890
2023
Q3 		$2.32M Buy
237,530
+39,805
+20% +$472K 0.02% 782
2023
Q2 		$2.34M Sell
197,725
-6,532
-3% -$74.9K 0.02% 701
2023
Q1 		$2.2M Sell
204,257
-1,143
-0.6% -$14.6K 0.02% 664
2022
Q4 		$2.37M Buy
205,400
+115,617
+129% +$1.43M 0.02% 756
2022
Q3 		$1.34M Sell
89,783
-118,817
-57% -$1.63M 0.01% 1091
2022
Q2 		$1.88M Sell
208,600
-32,700
-14% -$223K 0.02% 763
2022
Q1 		$1.81M Sell
241,300
-4,100
-2% -$28.6K 0.02% 779
2021
Q4 		$2.1M Sell
245,400
-26,800
-10% -$233K 0.02% 687
2021
Q3 		$2.29M Sell
272,200
-1,500
-0.5% -$11.5K 0.02% 671
2021
Q2 		$2.22M Buy
273,700
+68,990
+34% +$583K 0.02% 677
2021
Q1 		$1.8M Buy
204,710
+82,234
+67% +$792K 0.02% 698
2020
Q4 		$1.38M Buy
+122,476
New +$1.35M 0.02% 704
2018
Q2 		– Sell
-18,250
Closed -$811K – 793
2018
Q1 		$811K Buy
+18,250
New +$811K 0.06% 374

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Schonfeld Strategic Advisors's COGT Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Cogent Biosciences (COGT) in Q1 2026: 112,463 shares worth $4.33M. The stake represents 0.03% of the portfolio and ranks #534 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in COGT as recently as Q1 2025.

Schonfeld Strategic Advisors first reported a position in COGT in Q1 2018 and has held it in 17 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Schonfeld Strategic Advisors held 112,463 shares of Cogent Biosciences worth $4.33M as of Q1 2026.
  • Cogent Biosciences was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Cogent Biosciences made up 0.03% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #534 holding.
  • Schonfeld Strategic Advisors first reported a position in Cogent Biosciences in Q1 2018 and has held it in 17 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.